Betapace Alternatives Compared
| Betapace | Sotalol | Magnesium sulfate |
|
|---|
| Betapace sotalol | Sotalol | Magnesium sulfate |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Ventricular Arrhythmia. Betapace may also be used for purposes not listed in this medication guide. |
Prescribed for Atrial Fibrillation, Ventricular Arrhythmia, Atrial Flutter. sotalol may also be used for purposes not listed in this medication guide. |
Prescribed for Seizure Prevention, Hypomagnesemia, Ventricular Arrhythmia, Barium Poisoning. magnesium sulfate may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Ventricular Arrhythmia
|
|||||||||||||||||||||||
| More about Betapace (sotalol) | More about Sotalol | More about Magnesium sulfate | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription and OTC |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Betapace has an average rating of 7.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 0% reported a negative effect. |
Sotalol has an average rating of 6.5 out of 10 from a total of 53 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 27% reported a negative effect. |
Magnesium sulfate has an average rating of 5.8 out of 10 from a total of 3 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Common side effects include: bradycardia, fatigue. See the full Betapace side effects document. |
Commonly reported side effects include: bradycardia, fatigue, headache. See the full sotalol side effects document. |
See the full magnesium sulfate side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Betapace prices and generic prices |
View all sotalol prices |
View all magnesium sulfate prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other sotalol brands include: Betapace AF, Sorine, Sotalol Hydrochloride AF, Sotylize | Betapace, Betapace AF, Sorine, Sotalol Hydrochloride AF, Sotylize | Epsom Salt | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
12 hours |
12 hours |
N/A |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 581 drugs are known to interact with Betapace:
|
A total of 581 drugs are known to interact with sotalol:
|
A total of 100 drugs are known to interact with magnesium sulfate:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
October 30, 1992 |
October 30, 1992 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.